151 related articles for article (PubMed ID: 1394207)
1. Expression level of the nm23 gene in clonal populations of metastatic murine and human neoplasms.
Radinsky R; Weisberg HZ; Staroselsky AN; Fidler IJ
Cancer Res; 1992 Oct; 52(20):5808-14. PubMed ID: 1394207
[TBL] [Abstract][Full Text] [Related]
2. Phorbol 12-myristate 13-acetate enhances nm23 gene expression in murine melanocytes but not in syngeneic B16-BL6 melanoma variants.
Huijzer JC; McFarland M; Niles RM; Meadows GG
J Cell Physiol; 1996 Mar; 166(3):487-94. PubMed ID: 8600152
[TBL] [Abstract][Full Text] [Related]
3. Somatic allelic deletion of nm23 in human cancer.
Leone A; McBride OW; Weston A; Wang MG; Anglard P; Cropp CS; Goepel JR; Lidereau R; Callahan R; Linehan WM
Cancer Res; 1991 May; 51(9):2490-3. PubMed ID: 2015608
[TBL] [Abstract][Full Text] [Related]
4. Tumor metastasis and nm23: current concepts.
Steeg PS; Cohn KH; Leone A
Cancer Cells; 1991 Jul; 3(7):257-62. PubMed ID: 1911039
[TBL] [Abstract][Full Text] [Related]
5. Two isotypes of murine nm23/nucleoside diphosphate kinase, nm23-M1 and nm23-M2, are involved in metastatic suppression of a murine melanoma line.
Baba H; Urano T; Okada K; Furukawa K; Nakayama E; Tanaka H; Iwasaki K; Shiku H
Cancer Res; 1995 May; 55(9):1977-81. PubMed ID: 7728768
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of nm23-H2/NDP kinase B in a human oral squamous cell carcinoma cell line results in reduced metastasis, differentiated phenotype in the metastatic site, and growth factor-independent proliferative activity in culture.
Miyazaki H; Fukuda M; Ishijima Y; Takagi Y; Iimura T; Negishi A; Hirayama R; Ishikawa N; Amagasa T; Kimura N
Clin Cancer Res; 1999 Dec; 5(12):4301-7. PubMed ID: 10632374
[TBL] [Abstract][Full Text] [Related]
7. [Nm23/NDP kinase and cancer metastasis].
Kimura N
Gan To Kagaku Ryoho; 1993 Feb; 20(3):332-7. PubMed ID: 8382464
[TBL] [Abstract][Full Text] [Related]
8. Identification of a second human nm23 gene, nm23-H2.
Stahl JA; Leone A; Rosengard AM; Porter L; King CR; Steeg PS
Cancer Res; 1991 Jan; 51(1):445-9. PubMed ID: 1988104
[TBL] [Abstract][Full Text] [Related]
9. Expression of nm23 in cell lines derived from patients with metastatic renal cell carcinoma.
Walther MM; Anglard P; Gnarra J; Pozzatti R; Venzon D; de la Rosa A; MacDonald NJ; Steeg PS; Linehan WM
J Urol; 1995 Jul; 154(1):278-82. PubMed ID: 7776445
[TBL] [Abstract][Full Text] [Related]
10. Transfection of the nm23-H1 gene into human hepatocarcinoma cell line inhibits the expression of sialyl Lewis X, alpha1,3 fucosyltransferase VII, and metastatic potential.
Liu F; Zhang Y; Zhang XY; Chen HL
J Cancer Res Clin Oncol; 2002 Apr; 128(4):189-96. PubMed ID: 11935309
[TBL] [Abstract][Full Text] [Related]
11. Association between NM23-H1 gene expression and metastasis of human uveal melanoma in an animal model.
Ma D; Luyten GP; Luider TM; Jager MJ; Niederkorn JY
Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2293-301. PubMed ID: 8843913
[TBL] [Abstract][Full Text] [Related]
12. [Molecular mechanism of reversing metastatic phenotype in human high-metastatic large cell lung cancer cell line L9981 by nm23-H1].
Che GW; Zhou QH; Zhu W; Wang YP; Qin Y; Liu LX; Chen XH; Sun YL; Sun ZF
Ai Zheng; 2005 Mar; 24(3):278-84. PubMed ID: 15757527
[TBL] [Abstract][Full Text] [Related]
13. Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: effects on tumor metastatic potential, colonization and enzymatic activity.
Leone A; Flatow U; VanHoutte K; Steeg PS
Oncogene; 1993 Sep; 8(9):2325-33. PubMed ID: 8395676
[TBL] [Abstract][Full Text] [Related]
14. Nm23/nucleoside diphosphate (NDP) kinase expression in human malignant melanomas: significance and implications in tumor biology.
Bodey B; Bodey B; Gröger AM; Siegel SE; Kaiser HE
Anticancer Res; 1997; 17(1A):505-11. PubMed ID: 9066703
[TBL] [Abstract][Full Text] [Related]
15. Suppressive role of the metastasis-related nm23-H1 gene in human ovarian carcinomas: association of high messenger RNA expression with lack of lymph node metastasis.
Viel A; Dall'Agnese L; Canzonieri V; Sopracordevole F; Capozzi E; Carbone A; Visentin MC; Boiocchi M
Cancer Res; 1995 Jun; 55(12):2645-50. PubMed ID: 7780979
[TBL] [Abstract][Full Text] [Related]
16. P53 is a regulator of the metastasis suppressor gene Nm23-H1.
Chen SL; Wu YS; Shieh HY; Yen CC; Shen JJ; Lin KH
Mol Carcinog; 2003 Apr; 36(4):204-14. PubMed ID: 12669312
[TBL] [Abstract][Full Text] [Related]
17. NDP-K/nm23 expression in human breast cancer in relation to relapse, survival, and other prognostic factors: an immunohistochemical study.
Sawan A; Lascu I; Veron M; Anderson JJ; Wright C; Horne CH; Angus B
J Pathol; 1994 Jan; 172(1):27-34. PubMed ID: 7931824
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of the promoter for the human metastasis suppressor gene nm23-H1.
de la Rosa A; Mikhak B; Steeg PS
Arch Med Res; 1996; 27(3):395-401. PubMed ID: 8854401
[TBL] [Abstract][Full Text] [Related]
19. NM23 gene expression in human prostatic carcinomas and benign prostatic hyperplasias: altered expression in combined androgen blockaded carcinomas.
Borchers H; Meyers FJ; Gumerlock PH; Stewart SL; deVere White RW
J Urol; 1996 Jun; 155(6):2080-4. PubMed ID: 8618340
[TBL] [Abstract][Full Text] [Related]
20. Reduced Nm23/Awd protein in tumour metastasis and aberrant Drosophila development.
Rosengard AM; Krutzsch HC; Shearn A; Biggs JR; Barker E; Margulies IM; King CR; Liotta LA; Steeg PS
Nature; 1989 Nov; 342(6246):177-80. PubMed ID: 2509941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
